Mast Therapeutics (MSTX) Drops 40% Following Comments at Rodman & Renshaw Conf.
- Wall St. edges higher as earnings gather pace
- Alibaba (BABA) Tops Q3 EPS by 17c, Revenues Rise 54%
- DuPont (DD) Tops Q4 EPS by 9c; Sees Merger Closing in First Half
- Johnson & Johnson (JNJ) Tops Q4 EPS by 2c; Guides Modestly Below the Street
- Pre-Open Stock Movers 01/24: (MPSX) (IIVI) (AKS) Higher; (FSM) (OCUL) (VZ) Lower (more...)
Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.
Mast Therapeutics (NYSE: MSTX) Drops 40% Following Comments at Rodman & Renshaw Conf.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Birks Group, Inc. (BGI) Climbs to Session High, Up 40%
- Options expected to have Increasing volume
- Alphabet (GOOGL) January weekly volatility increases into Q4 and outlook
Create E-mail Alert Related CategoriesMomentum Movers, Trader Talk
Related EntitiesRodman & Renshaw
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!